Solvay (SOL0) AI Stock Analysis

Solvay

(Frankfurt:SOL0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Diversified specialty chemicals portfolioSolvay’s portfolio spans specialty materials, advanced polymers, composites, and chemical solutions across multiple industrial end markets. This breadth can reduce dependence on any single customer or application and supports durable demand where performance, light weighting, and chemical resistance matter.

Negative Factors

Sharp profitability deteriorationNear-breakeven net income and a negative net margin show that the current earnings base is fragile, while revenue contraction reduces operating leverage. Although gross margin and EBITDA remain positive, weaker profitability limits reinvestment capacity and makes results more sensitive to demand and pricing pressure.

Solvay (SOL0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 2.71B
Dividend Yield: 9.57%
Average Volume (3M): 213
Price to Earnings (P/E): 1191.0
Beta (1Y): 1.07
Revenue Growth: -7.71%
EPS Growth: -97.90%
Country: Germany
Employees: 8,443
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals

Solvay Business Overview & Revenue Model

Company Description

Solvay S.A. is a global enterprise specializing in high-performance materials and an array of unique chemical products. Its operations are structured into four primary divisions: Materials, Chemicals, Solutions, and Corporate & Business Services. The...

Solvay Earnings Call Summary

Earnings Call Date:Jul 28, 2026(Q2-2026)|% Change Since:-9.84%|Next Earnings Date:Nov 03, 2026

Earnings Call SentimentNeutral

The call presented a mixed picture: clear strategic progress (record bicarbonate and electronic‑grade peroxide demand, rare‑earth investments and contracts, confirmed 2026 guidance, cost savings and a maintained investment‑grade rating) contrasted with significant near‑term operational headwinds (7% sales decline, 20% EBITDA decline, temporary EUR 20m hit from the Middle East plant shutdown, weak soda ash seaborne markets, modest H1 free cash flow and substantial transformation cash costs). Management confirmed guidance and is prioritizing long‑term transformation and selective growth, but near‑term metrics remain under pressure.

Positive Updates

Record demand in bicarbonate and electronic‑grade peroxides

Management reported record sales levels for bicarbonate and for electronic‑grade hydrogen peroxide (driven by semiconductor/AI demand). Electronic‑grade growth helped mitigate weaker volumes elsewhere.

Negative Updates

Material YoY topline and EBITDA decline in Q2

Underlying net sales in Q2 were slightly over EUR 1 billion, down 7% year‑on‑year. Underlying EBITDA fell to EUR 187 million, down 20% YoY, with EBITDA margin at 18.1%.

Company Guidance

The company confirmed its 2026 guidance, reiterating an underlying EBITDA target of EUR 770–850 million, free cash flow to Solvay shareholders from continuing operations to exceed EUR 200 million, and CapEx of around EUR 300 million, with this outlook explicitly assuming the restart of the peroxides (Sadara) plant before the end of Q3; management also noted temporary transformation-related cash outflows of ~EUR 90 million in 2026 (EUR 50 million expected in 2027). Key first-half metrics include underlying net sales just over EUR 1 billion in Q2, underlying EBITDA of EUR 187 million (18.1% margin) in Q2, free cash flow of EUR 15 million for H1 (Q2 at -EUR 11 million), CapEx ~EUR 140 million in H1, working capital outflow of -EUR 79 million and cash outflows from provisions of EUR 106 million; net debt stood at EUR 1.8 billion at end‑June, leverage temporarily above 2x after a EUR 254 million dividend payment but expected to be around 2x by year‑end, and the group retains a BBB- S&P rating.

Solvay Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:SOL0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DD	62Neutral	$18.91B	304.46	0.34%	1.71%	-34.44%	―
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DOW	60Neutral	$25.12B	-27.54	-4.50%	4.03%	4.16%	20.86%
CE	56Neutral	$5.41B	-4.62	-28.81%	0.24%	-2.28%	27.94%
HUN	55Neutral	$1.69B	-9.69	-6.28%	3.63%	0.65%	45.36%
OLN	54Neutral	$2.01B	-11.97	-9.57%	4.55%	-0.73%	-415.18%

* Basic Materials Sector Average

Performance Comparison

DE:SOL0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:SOL0	Solvay Sa Adr	2.20	-0.12	-5.21%
CE	Celanese	49.30	12.33	33.34%
HUN	Huntsman	9.64	1.87	24.05%
OLN	Olin Corporation	17.60	-1.74	-8.99%
DD	DuPont de Nemours, Inc.	140.05	37.78	36.94%
DOW	Dow Inc.	34.70	12.56	56.75%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Solvay AI Stock Analysis